68071 4517 9
Sildenafil Tablet, Film Coated
Product Images NDC 68071-4517
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-4517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-10 (Sildenafil Fig 10)
Figure-11 (Sildenafil Fig 11)
Fig-12 (Sildenafil Fig 12)
Fig-6 (Sildenafil Fig 6)
Fig-8 (Sildenafil Fig 8)
This is a drug interaction table with recommendations for dose adjustment of various drugs when used in combination with other drugs. The table includes information on drug names, the need for dose adjustments, and the suggested fold change along with 90% confidence intervals.*
Figure-9 (Sildenafil Fig 9)
Figure-7 (Sildenafil Figure 7)
This text appears to be a table listing different drugs with recommendations on dose adjustments based on their effect on certain metrics like AUC and Cmax. It also includes a note on the interaction of different drugs and their relative fold change. There is a reference to a graph with a solid line at x=1 and a note on the lack of benefit on exercise capacity when sildenafil is added to bosentan therapy which is explained in Clinical Studies (14).*
Str (Sildenafil Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
